Cargando…

Bioaccessibility Study of Aflatoxin B(1) and Ochratoxin A in Bread Enriched with Fermented Milk Whey and/or Pumpkin

The presence of mycotoxins in cereals and cereal products remains a significant issue. The use of natural ingredients such as pumpkin and whey, which contain bioactive compounds, could be a strategy to reduce the use of conventional chemical preservatives. The aim of the present work was to study th...

Descripción completa

Detalles Bibliográficos
Autores principales: Escrivá, Laura, Agahi, Fojan, Vila-Donat, Pilar, Mañes, Jordi, Meca, Giuseppe, Manyes, Lara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8779489/
https://www.ncbi.nlm.nih.gov/pubmed/35050983
http://dx.doi.org/10.3390/toxins14010006
_version_ 1784637589900230656
author Escrivá, Laura
Agahi, Fojan
Vila-Donat, Pilar
Mañes, Jordi
Meca, Giuseppe
Manyes, Lara
author_facet Escrivá, Laura
Agahi, Fojan
Vila-Donat, Pilar
Mañes, Jordi
Meca, Giuseppe
Manyes, Lara
author_sort Escrivá, Laura
collection PubMed
description The presence of mycotoxins in cereals and cereal products remains a significant issue. The use of natural ingredients such as pumpkin and whey, which contain bioactive compounds, could be a strategy to reduce the use of conventional chemical preservatives. The aim of the present work was to study the bioaccessibility of aflatoxin B(1) (AFB1) and ochratoxin (OTA) in bread, as well as to evaluate the effect of milk whey (with and without lactic acid bacteria fermentation) and pumpkin on reducing mycotoxins bioaccessibility. Different bread typologies were prepared and subjected to an in vitro digestion model. Gastric and intestinal extracts were analyzed by HPLC–MS/qTOF and mycotoxins bioaccessibility was calculated. All the tested ingredients but one significantly reduced mycotoxin intestinal bioaccessibility. Pumpkin powder demonstrated to be the most effective ingredient showing significant reductions of AFB1 and OTA bioaccessibility up to 74% and 34%, respectively. Whey, fermented whey, and the combination of pumpkin-fermented whey showed intestinal bioaccessibility reductions between 57–68% for AFB1, and between 11–20% for OTA. These results pointed to pumpkin and milk whey as potential bioactive ingredients that may have promising applications in the bakery industry.
format Online
Article
Text
id pubmed-8779489
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-87794892022-01-22 Bioaccessibility Study of Aflatoxin B(1) and Ochratoxin A in Bread Enriched with Fermented Milk Whey and/or Pumpkin Escrivá, Laura Agahi, Fojan Vila-Donat, Pilar Mañes, Jordi Meca, Giuseppe Manyes, Lara Toxins (Basel) Article The presence of mycotoxins in cereals and cereal products remains a significant issue. The use of natural ingredients such as pumpkin and whey, which contain bioactive compounds, could be a strategy to reduce the use of conventional chemical preservatives. The aim of the present work was to study the bioaccessibility of aflatoxin B(1) (AFB1) and ochratoxin (OTA) in bread, as well as to evaluate the effect of milk whey (with and without lactic acid bacteria fermentation) and pumpkin on reducing mycotoxins bioaccessibility. Different bread typologies were prepared and subjected to an in vitro digestion model. Gastric and intestinal extracts were analyzed by HPLC–MS/qTOF and mycotoxins bioaccessibility was calculated. All the tested ingredients but one significantly reduced mycotoxin intestinal bioaccessibility. Pumpkin powder demonstrated to be the most effective ingredient showing significant reductions of AFB1 and OTA bioaccessibility up to 74% and 34%, respectively. Whey, fermented whey, and the combination of pumpkin-fermented whey showed intestinal bioaccessibility reductions between 57–68% for AFB1, and between 11–20% for OTA. These results pointed to pumpkin and milk whey as potential bioactive ingredients that may have promising applications in the bakery industry. MDPI 2021-12-22 /pmc/articles/PMC8779489/ /pubmed/35050983 http://dx.doi.org/10.3390/toxins14010006 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Escrivá, Laura
Agahi, Fojan
Vila-Donat, Pilar
Mañes, Jordi
Meca, Giuseppe
Manyes, Lara
Bioaccessibility Study of Aflatoxin B(1) and Ochratoxin A in Bread Enriched with Fermented Milk Whey and/or Pumpkin
title Bioaccessibility Study of Aflatoxin B(1) and Ochratoxin A in Bread Enriched with Fermented Milk Whey and/or Pumpkin
title_full Bioaccessibility Study of Aflatoxin B(1) and Ochratoxin A in Bread Enriched with Fermented Milk Whey and/or Pumpkin
title_fullStr Bioaccessibility Study of Aflatoxin B(1) and Ochratoxin A in Bread Enriched with Fermented Milk Whey and/or Pumpkin
title_full_unstemmed Bioaccessibility Study of Aflatoxin B(1) and Ochratoxin A in Bread Enriched with Fermented Milk Whey and/or Pumpkin
title_short Bioaccessibility Study of Aflatoxin B(1) and Ochratoxin A in Bread Enriched with Fermented Milk Whey and/or Pumpkin
title_sort bioaccessibility study of aflatoxin b(1) and ochratoxin a in bread enriched with fermented milk whey and/or pumpkin
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8779489/
https://www.ncbi.nlm.nih.gov/pubmed/35050983
http://dx.doi.org/10.3390/toxins14010006
work_keys_str_mv AT escrivalaura bioaccessibilitystudyofaflatoxinb1andochratoxinainbreadenrichedwithfermentedmilkwheyandorpumpkin
AT agahifojan bioaccessibilitystudyofaflatoxinb1andochratoxinainbreadenrichedwithfermentedmilkwheyandorpumpkin
AT viladonatpilar bioaccessibilitystudyofaflatoxinb1andochratoxinainbreadenrichedwithfermentedmilkwheyandorpumpkin
AT manesjordi bioaccessibilitystudyofaflatoxinb1andochratoxinainbreadenrichedwithfermentedmilkwheyandorpumpkin
AT mecagiuseppe bioaccessibilitystudyofaflatoxinb1andochratoxinainbreadenrichedwithfermentedmilkwheyandorpumpkin
AT manyeslara bioaccessibilitystudyofaflatoxinb1andochratoxinainbreadenrichedwithfermentedmilkwheyandorpumpkin